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General. Unless stated otherwise, all reactions were carried out under Ar in flame-dried glassware. 
The solvents used were purified by distillation over the drying agents indicated and were transferred 
under Ar: Et2O (Mg/anthracene), CH2Cl2 (CaH2), pentane, toluene (Na/K), MeOH (Mg). Flash 
chromatography (FC): Merck silica gel 60 (230–400 mesh). NMR: Spectra were recorded on Bruker 
DPX 300, AMX 300 or AV 400 spectrometers in the solvents indicated; chemical shifts (δ) are given in 
ppm relative to TMS, coupling constants (J) in Hz. The solvent signals were used as references and 
the chemical shifts converted to the TMS scale (CDCl3: δC  77.0 ppm; residual CHCl3 in CDCl3: δH  
7.26 ppm; CD2Cl2: δC  53.8 ppm; residual 
1H: δH  5.32 ppm; [D8]-toluene: δC  20.7 ppm; residual 
D5C6CD2H: δH  2.09 ppm). IR: Spectrum One (Perkin-Elmer) spectrometer, wavenumbers (
~ ) in 
cm1. MS (EI): Finnigan MAT 8200 (70 eV), ESI-MS: ESQ3000 (Bruker), accurate mass determinations: 
Bruker APEX III FT-MS (7 T magnet) or Mat 95 (Finnigan). Elemental analyses: H. Kolbe, 
Mülheim/Ruhr. All commercially available compounds (Fluka, Lancaster, Aldrich) were used as 
received, unless stated otherwise. 
1,10-Phenanthroline and 2,2’-bipyridine were purified and dried by two subsequent sublimations of 
the commercial sample (Aldrich, ≥ 99%) under vacuum (10–3 mbar). 
Anhydrous ZnCl2 was prepared by heating a finely ground commercial sample (Aldrich, ≥ 98%) to 
100°C under vacuum (10–3 mbar). 
 
[Mo(CHCMe2Ph)(NAr)(OCMe(CF3)2)2(phen)] (Ar = 2,-6-diisopropylphenyl, 2). A solution of 
[Mo(CHCMe2Ph)(NAr)(OCMe(CF3)2)2] (1, 326 mg, 426 μmol) in toluene 
(3 mL) was added to a solution of 1,10‐phenanthroline (doubly 
sublimed, 77 mg, 426 μmol) in toluene (2 mL). After stirring for 1 h, 
the precipitate was filtered off and washed with cold toluene (2 mL). 
The filtrate was concentrated and cooled to –40°C to yield an 
additional crop of yellow crystals. The two crops were combined and 
dried in vacuo to give complex 2 as a yellow solid (384 mg, 95%). 1H 
NMR (400 MHz, CD2Cl2): δ = 13.88 (s, 1H), 9.48 (dd, J = 4.7, 1.6 Hz, 1H), 8.41 (dd, J = 8.3, 1.6 Hz, 1H), 
8.37 (dd, J = 8.3, 1.6 Hz, 1H), 7.98 (dd, J = 5.2, 1.3 Hz, 1H), 7.92 (d, J = 8.9 Hz, 1H), 7.86-7.82 (m, 2H), 
7.67 (dd, J = 8.5, 1.0 Hz, 2H), 7.46 (t, J = 8.1 Hz, 2H), 7.33 (t, J = 7.3 Hz, 1H), 7.30 (dd, J = 8.2, 5.6 Hz, 
1H), 6.91 (br s, 1H), 6.80 (t, J = 7.6 Hz, 1H), 6.71 (br s, 1H), 4.38 (br s, 1H), 3.13 (br s, 1H), 2.07 (s, 3H), 
1.68 (s, 3H), 1.65 (s, 3H), 1.19 (br s, 6H), 0.85 (br s, 3H), 0.26 (s, 3H), –0.55 ppm (br s, 3H); 13C NMR 
(100 MHz, CD2Cl2): δ = 309.6, 158.9, 150.5, 150.0, 149.6, 149.5, 145.8, 143.4, 139.3, 138.4, 138.0, 
130.4, 129.9, 129.4, 128.7, 128.6, 127.9, 126.9, 126.7, 126.4, 126.3, 125.6, 125.1, 124.9, 80.1, 55.0, 
32.0, 28.8, 28.2, 26.9, 26.6, 24.7, 24.3, 22.6, 21.5, 17.9, 17.6 ppm; 19F NMR (377 MHz, CD2Cl2): δ = –
76.3 (q, J = 10.3 Hz, 3F), –77.4 (m, 3F), –77.6 (q, J = 10.3 Hz, 3F), –77.9 ppm (m, 3F); IR (film, cm-1): 
2966, 2868, 1578, 1424, 1296, 1214, 1163, 1105, 1070, 958, 844, 762, 727, 697. HRMS (ESI+): m/z: 
calcd for [M+ – OC(CF3)2(CH3)]: 766.2130; found: 766.2145. 
According to 1H NMR, ca. 50% of this material were intact after storage on the bench in an open flask 




































































Figure S-1. Structure of [Mo(CHCMe2Ph)(NAr)(OCMe(CF3)2)2(phen)] (Ar = 2,6-diisopropylphenyl) (2) in 
the solid state. The crystal contained traces of toluene, which made the treatment of the recorded 
dataset with the SQUEEZE program necessary to improve the R-value from 13% to 6.6%. Despite this 
mathematical correction, the connectivity as shown in this Figure is unambiguous. For further details, 
see CCDC-816986 
[Mo(CHCMe2Ph)(NAr)(OCMe(CF3)2)2(bipy)] (Ar = 2,-6-diisopropylphenyl, 3). A solution of 
[Mo(CHCMe2Ph)(NAr)(OCMe(CF3)2)2] (1, 316 mg, 413 μmol) in toluene 
(3 mL) was added to a solution of 2,2′-bipyridine (doubly sublimed, 
65 mg, 413 μmol) in toluene (2 mL). After stirring for 1 h the 
precipitate was filtered off and washed with cold toluene (2 mL). The 
filtrate was concentrated and then cooled to –40°C to yield an 
additional crop of yellow crystals. The two crops were combined and 
dried in vacuo to give complex 3 as a yellow solid (354 mg, 93%). 1H 
NMR (400 MHz, CD2Cl2): δ = 13.74 (s, 1H), 9.22 (dd, J = 5.1, 1.6 Hz, 1H), 
8.02 (d, J = 8.0 Hz, 1H), 7.97 (d, J = 8.1 Hz, 1H), 7.92-7.84 (m, 2H), 7.76 (d, J = 4.6 Hz, 1H), 7.62 (d, J = 
8.2 Hz, 2H), 7.54 (ddd, J = 7.4, 5.2, 1.3 Hz, 1H), 7.41 (t, J = 7.4 Hz, 2H), 7.28 (tt, J = 7.3, 1.2 Hz, 1H), 
6.96 (ddd, J = 7.4, 5.6, 1.3 Hz, 1H), 9.92 (br s, 1H), 6.88 (t, J = 7.0 Hz, 1H), 6.84 (br s, 1H), 4.19 (br s, 
1H), 3.16 (br s, 1H), 2.02 (s, 3H), 1.63 (s, 3H), 1.61 (s, 3H), 1.24 (br s, 3H), 1.12 (br s, 3H), 0.81 (br s, 
3H), 0.55 (s, 3H), –0.09 ppm (br s, 3H); 13C NMR (100 MHz, CD2Cl2): δ = 309.0, 159.7, 154.9, 153.1, 
151.5, 150.3, 149.9, 149.7, 149.6, 148.0, 140.0, 139.2, 128.5, 126.8, 126.4, 126.3, 126.2, 122.8, 121.4, 
80.1, 54.8, 31.9, 28.7, 28.5, 26.9, 26.1, 25.0, 24.5, 22.6, 17.7 ppm; 19F NMR (377 MHz, CD2Cl2): δ = –
76.4 (q, J = 10.3 Hz, 3F), –77.1 (q, J = 10.3 Hz, 3F), –77.4 (m, 3F), –77.7 ppm (m, 3F); IR (film, cm-1): 
2968, 2868, 1599, 1443, 1296, 1210, 1165, 1078, 1024, 955, 757, 697. HRMS (ESI): m/z: calcd. for 
C36H40MoF6N3O: 742.2130; found 742.2144 [M
+ – OC(CF3)2(CH3)]; elemental analysis (%) calcd for 
C40H43F12MoN3O2: C 52.12, H 4.70, N 4.56, F 24.73; found: C 52.19, H 4.72, N 4.49, F 24.66. 
According to 1H NMR, this complex is fully intact after storage on the bench in an open flask for eight 




Figure S-2. 1H NMR spectrum of complex 3 in CD2Cl2 recorded immediately after preparation (green), 
and after storage in air for 4 weeks (red) or 8 weeks (blue). 
 
Figure S-3. 1H NMR spectra (CD2Cl2) of the bipyridine adduct 3 (green), the original Schrock alkylidene 
1 from which this adduct is derived (red), and the complex released in solution upon treatment of 
adduct 3 with ZnCl2 in CD2Cl2 at 100°C for 1h in a closed NMR tube (blue). 
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 [Mo(CH-tBu)(NAr)(OSiPh3)2(phen)] (Ar = 2,-6-diisopropylphenyl, 5a). A solution of Ph3SiOK (302 mg, 
959 μmol) in toluene (5 mL) was added to a solution of [Mo(CH-t-
Bu)(NAr)(OSO2CF3)2(dme)] (350 mg, 480 μmol) in toluene (5 mL). After 
stirring for 1 h, the mixture was filtered and the filtrate added to a solution 
of 1,10‐phenanthroline (doubly sublimed, 87 mg, 480 μmol) in toluene 
(5 mL). After stirring for 1 h and removal of the solvent, the residue was 
dissolved in the minimum amount of CH2Cl2 (≤ 5 mL) and the product 
precipitated with pentane (25 mL). The precipitate was filtered off and 
dried in vacuo to give complex 5a as a yellow solid (417 mg, 81%). 1H NMR (400 MHz, CD2Cl2): δ = 
13.63 (s, 1H), 9.76 (dd, J = 4.7, 1.6 Hz, 1H), 9.30 (dd, J = 5.1, 1.5 Hz, 1H), 8.26 (dd, J = 8.2, 1.6 Hz, 1H), 
7.94 (dd, J = 8.2, 1.4 Hz, 1H), 7.84 (dd, J = 8.0, 1.4 Hz, 6H), 7.72 (d J = 8.8 Hz, 1H), 7.61 (dd, J = 8.2, 4.7 
Hz, 1H), 7.50 (d, J = 8.8 Hz, 1H), 7.41 (dd, J = 8.2, 5.2 Hz, 1H), 7.23 (tt, J = 7.4, 1.4 Hz, 3H), 7.08-7.03 
(m, 9H), 7.00 (dd, J = 8.0, 1.4 Hz, 6H), 6.80 (t, J = 7.4 Hz, 6H), 6.72-6.71 (m, 3H), 4.37 (br s, 1H), 3.66 
(br s, 1H), 1.20 (s, 9H), 1.14 (br s, 3H), 0.50 (br s, 6H), –0.43 ppm (br s, 3H);13C NMR (100 MHz, 
CD2Cl2): δ = 304.9, 158.1, 150.2, 149.5, 145.0, 143.3, 141.4, 140.6, 138.6, 137.4, 136.7, 135.5, 135.3, 
130.5, 130.1, 130.0, 128.5, 128.3, 128.0, 127.5, 127.4, 127.2, 127.0, 125.2, 124.9, 124.2, 123.1, 49.0, 
32.0 ppm; IR (film, cm-1): 2936, 2866, 1513, 1423, 1256, 1144, 1106, 1032, 947, 842, 760, 698. HRMS 
(ESI+): m/z: calcd for [M+ – OSiPh3]: 798.2777; found: 798.2795; elemental analysis (%) calcd for 
C65H65MoN3O2Si2: C 72.80, H 6.11, N 3.92; found: C 72.48, H 6.19, N 3.88. 
[Mo(CHCMe2Ph)(NAr)(OSiPh3)2(phen)] (Ar = 2,-6-diisopropylphenyl, 5b). Prepared as described 
above from Ph3SiOK (300 mg, 955 μmol), 
[Mo(CHCMe2Ph)(NAr)(OSO2CF3)2(dme)] (378 mg, 477 μmol) and 
1,10‐phenanthroline (doubly sublimed, 86 mg, 477 μmol). Yellow solid 
(460 mg, 85%). 1H NMR (400 MHz, CD2Cl2): δ = 13.61 (s, 1H), 9.78 (dd, J = 
4.7, 1.6 Hz, 1H), 8.22 (dd, J = 8.2, 1.5 Hz, 1H), 7.91 (dd, J = 5.2, 1.5 Hz, 1H), 
7.85 (dd, J = 8.0, 1.4 Hz, 6H), 7.76 (dd, J = 8.2, 1.5 Hz, 1H), 7.62-7.58 (m, 
4H), 7.48 (t, J = 7.6 Hz, 2H), 7.36 (t, J = 8.8 Hz, 1H), 7.25 (tt, J = 7.4, 1.4 Hz, 
3H), 7.09-7.02 (m, 10H), 6.91 (dd, J = 8.0, 1.4 Hz, 6H), 6.86 (dd, J = 5.1, 3.0 Hz, 1H), 6.77 (t, J = 7.6 Hz, 
6H), 6.74 (m, 3H), 4.53 (br s, 1H), 3.20 (br s, 1H), 2.20 (s, 3H), 1.20 (br s, 3H), 0.93 (s, 3H), 0.56 (br s, 
6H), –0.67 ppm (br s, 3H); 13C NMR (100 MHz, CD2Cl2): δ = 300.2, 157.5, 151.4, 150.2, 149.3, 144.6, 
143.2, 141.4, 140.4, 138.3, 137.4, 136.7, 136.3, 135.4, 135.3, 130.5, 129.9, 129.8, 128.6, 128.3, 128.0, 
127.8, 127.5, 127.4, 127.2, 127.0, 126.9, 126.1, 125.4, 124.5, 124.1, 54.6, 31.2, 28.3, 28.2, 22.6 ppm. 
























































































Figure S-4. Structure of [Mo(CHCMe2Ph)(NAr)(OSiPh3)2(phen)] (Ar = 2,6-diisopropylphenyl) (5b) in the 
solid state. For further information, see CCDC-816984 
 
 [Mo(CHCMe2Ph)(NAr)((R)-(+)-tBu2Me4(biphen))(bipy)] (Ar = 2,-6-diisopropylphenyl, 7). A solution 
of [Mo(CHCMe2Ph)(NAr)((R)-(+)-tert-Bu2Me4(biphen)] (6) (316 mg, 
418 μmol) in Et2O (3 mL) was added to a solution of 2,2’-bipyridine 
(doubly sublimed, 65 mg, 418 μmol) in Et2O (2 mL). After stirring for 
1 h the solvent was evaporated and the residue recrystallized by 
slowly cooling a solution in pentane to –40°C. The product was dried 
in vacuo to give complex 7 as an orange-red solid (282 mg, 74%). 1H 
NMR (400 MHz, CD2Cl2): δ = 13.03 (s, 1H), 8.62 (dd, J = 5.2, 1.8 Hz, 
1H), 7.87 (d, J = 8.0 Hz, 1H), 7.79 (d, J = 8.2 Hz, 1H), 7.74-7.68 (m, 
2H), 7.56 (dd, J = 8.5, 1.2 Hz, 2H), 7.36-7.31 (m, 3H), 7.19 (tt, J = 7.2, 1.2 Hz, 1H), 6.98 (s, 1H), 6.94 
(ddd, J = 7.4, 5.2, 1.1 Hz, 1H), 6.83 (ddd, J = 7.4, 5.4, 1.2 Hz, 1H), 6.79-6.74 (m, 3H), 6.35 (s, 1H), 4.18 
(br s, 1H), 3.65 (br s, 1H), 2.24 (s, 3H), 2.12 (s, 3H), 1.73 (s, 3H), 1.57 (s, 3H), 1.54 (s, 3H), 1.49 (s, 9H), 
1.28 (br s, 3H), 1.04 (s, 6H), 0.71 (br s, 3H), 0.68 (s, 9H), –0.01 ppm (br s, 3H); 13C NMR (100 MHz, 
CD2Cl2): δ = 305.3, 168.6, 162.2, 157.9, 154.4, 151.9, 151.6, 150.7, 150.4, 149.5, 148.8, 148.6, 146.9, 
138.7, 138.4, 137.2, 133.8, 133.6, 133.2, 132.4, 132.0, 131.5, 129.2, 128.4, 127.2, 126.4, 125.7, 125.4, 
125.3, 125.0, 124.9, 124.8, 122.6, 122.0, 121.2, 35.0, 34.8, 34.5, 32.1, 32.0, 31.5, 29.7, 27.4, 26.4, 
25.2, 24.2, 22.6, 20.3, 20.1, 19.9, 16.4, 16.0, 15.8, 14.2 ppm; IR (film, cm-1): 2920, 2862, 1738, 1595, 





Representative Olefin Metathesis Reaction using [Mo(CHCMe2Ph)(NAr)(OCMe(CF3)2)2(bipy)] 
Activated by ZnCl2. A solution containing complex 3 (23 mg, 25 μmol, 5 mol%) and anhydrous ZnCl2 
(3.4 mg, 25 μmol) in toluene (2.5 mL) was stirred at 100°C for 30 min. After this activation phase, the 
mixture was allowed to reach ambient temperature before diethyl 2,2-diallylmalonate (121 μL, 
500 μmol) was introduced; stirring was continued for 10 min before all volatile materials were 
evaporated. The dark brown residue was purified by flash chromatography (silica, hexanes/EtOAc, 
40:1) to afford diethyl cyclopent-3-ene-1,1-dicarboxylate as a colorless oil (104 mg, 98%). 1H NMR 
(400 MHz, CDCl3): δ = 5.59 (s, 2H), 4.19 (q, J = 7.1 Hz, 4H), 3.00 (s, 4H), 1.24 ppm (t, J = 7.1 Hz, 6H); 
13C 
NMR (100 MHz, CDCl3): δ = 172.4, 127.9, 61.6, 59.0, 41.0, 14.2 ppm; IR (film, cm
-1): 3463, 2982, 2872, 
1728, 1446, 1366, 1248, 1179, 1060, 1015, 951, 695; MS (EI) m/z (%): 212 [M+] (25), 166 (45), 138 
(100), 111 (41), 93 (39), 79 (56), 66 (76), 55 (5), 39 (16), 29 (97); HRMS (ESI): m/z: calcd for C11H16O4 + 
Na: 235.0946; found: 235.0941. The analytical and spectroscopic data are in accordance with those 
reported in the literature.1 
Diethyl 3,4-dimethylcyclopent-3-ene-1,1-dicarboxylate. Colorless oil. 1H NMR (400 MHz, CDCl3): δ = 
4.18 (q, J = 7.1 Hz, 4H), 2.92 (s, 4H), 1.58 (s, 6H), 1.23 ppm (t, J = 7.1 Hz, 6H); 13C 
NMR (100 MHz, CDCl3): δ = 172.7, 128.2, 122.9, 61.5, 57.3, 46.0, 28.1, 22.6, 14.2, 
13.4 ppm; IR (film, cm-1): 3462, 2970, 2859, 1729, 1443, 1366, 1246, 1180, 1071, 
1019; MS (EI) m/z (%): 240 [M+] (26), 195 (7), 166 (100), 138 (11), 121 (23), 107 (15), 
93 (42), 79 (17), 29 (30); HRMS (ESI): m/z: calcd for C13H20O4 + Na: 263.1259; found: 263.1254. The 
analytical and spectroscopic data are in accordance with those reported in the literature.2 
Diethyl 3-tert-butylcyclopent-3-ene-1,1-dicarboxylate. Colorless oil. 1H NMR (400 MHz, CDCl3): δ = 
5.17 (s, 1H), 4.18 (q, J = 7.1 Hz, 4H), 2.94 (s, 4H), 1.23 (t, J = 7.1 Hz, 6H), 1.04 ppm (s, 
9H); 13C NMR (100 MHz, CDCl3): δ = 172.4, 151.1, 117.6, 61.5, 59.6, 40.3, 39.9, 32.8, 
29.0, 14.2 ppm; IR (film, cm-1): 3462, 2964, 2869, 1730, 1446, 1364, 1245, 1183, 
1060, 1024, 815, 737; MS (EI) m/z (%): 268 [M+] (24), 223 (8), 194 (58), 179 (82), 151 
(14), 138 (20), 133 (22), 121 (100), 107 (82), 91 (21), 79 (12), 65 (7), 57 (26), 41 (14), 
29 (58); HRMS (ESI): m/z: calcd for C15H24O4 + Na: 291.1572; found: 291.1567. The 
analytical and spectroscopic data are in accordance with those reported in the literature.2 
Diethyl 3-phenylcyclopent-3-en-1,1-dicarboxylate. Yellow oil. 1H NMR (400 MHz, CDCl3): δ = 7.38-
7.35 (m, 2H), 7.28-7.24 (m, 2H), 7.18 (tt, J = 7.3, 1.3 Hz, 1H), 5.97-5.95 (m, 1H), 4.18 
(q, J = 7.1 Hz, 4H), 3.36 (q, J = 2.0 Hz, 2H), 3.16 (q, J = 2.3 Hz, 2H), 1.21 (t, J = 7.1 Hz, 
6H); 13C NMR (100 MHz, CDCl3): δ = 172.2, 139.6, 135.5, 128.5, 127.6, 125.7, 122.4, 
61.8, 59.1, 41.3, 41.2, 14.2; IR (neat, cm-1): 2981, 1728, 1495, 1446, 1366, 1243, 
1180, 1156, 1096, 1071, 1055, 1014, 862, 746, 691; MS (EI) m/z (%): 288 [M+] (48), 
243 (10), 214 (100), 186 (8), 169 (18), 155 (12), 141 (60), 128 (6), 115 (12), 91 (4), 29 (12); HRMS (ESI): 
m/z: calcd for C17H20O4+Na: 311.1259; found: 311.1254. The analytical and spectroscopic data are in 
accordance with those reported in the literature.2 
Triethyl cyclopent-3-en-1,1,3-tricarboxylate. Yellow oil. 1H NMR (400 MHz, 
CDCl3): δ =  6.58 (quin, J = 2.2 Hz, 1H), 4.19 (q, J = 7.1 Hz, 4H), 4.17 (q, J = 7.0 Hz, 
2H), 3.24 (q, J = 2.1 Hz, 2H), 3.16 (q, J = 2.4 Hz, 2H), 1.26 (t, J = 7.1 Hz, 3H), 1.23 (t, 
J = 7.1 Hz, 6H); 13C NMR (100 MHz, CDCl3): δ =  171.5, 164.2, 139.5, 133.9, 61.9, 
                                                          
1
 W. A. Nugent, J. Feldman, J. C. Calabrese, J. Am. Chem. Soc. 1995, 117, 8992-8998. 
2
 T. A. Kirkland, R. H. Grubbs, J. Org. Chem. 1997, 62, 7310-7318. 
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60.5, 58.8, 41.2, 39.6, 14.3, 14.1; IR (neat, cm-1): 2982, 1730, 1713, 1641, 1446, 1368, 1237, 1180, 
1109, 1065, 1014, 859, 732; MS (EI) m/z (%): 284 [M+] (15), 238 (100), 211 (25), 192 (14), 182 (7), 165 
(98), 138 (38), 110 (31), 93 (21), 79 (4), 65 (21), 53 (4), 39 (4), 29 (49); HRMS (ESI): m/z: calcd for 
C14H20O6+Na: 307.1158; found: 307.1152. The analytical and spectroscopic data are in accordance 
with those reported in the literature.2 
Diethyl 3,4-dimethylcyclohex-3-en-1,1-dicarboxylate. Yellow oil. 1H NMR (400 MHz, CDCl3): δ =  4.17 
(q, J = 7.1 Hz, 4H), 2.43 (s, 2H), 2.09 (t, J = 3.6 Hz, 2H), 1.99-1.96 (m, 2H), 1.63 (s, 
3H), 1.57 (s, 3H), 1.22 (t, J = 7.1 Hz, 6H); 13C NMR (100 MHz, CDCl3): δ =  171.9, 
124.7, 123.0, 61.3, 53.9, 36.6, 28.8, 28.1, 19.1, 18.9, 14.2; IR (neat, cm-1): 2981, 
2911, 1730, 1444, 1366, 1296, 1241, 1227, 1174, 1129, 1087, 1052, 1028, 861. MS 
(EI) m/z (%): 254 [M+] (28), 209 (10), 180 (76), 165 (30), 151 (18), 137 (12), 107 
(100), 93 (16), 79 (8), 67 (5), 53 (3), 41 (7), 29 (25); HRMS (ESI): m/z: calcd for C14H22O4: 254.1518; 
found: 254.1518. The analytical and spectroscopic data are in accordance with those reported in the 
literature.2 
Diethyl 3-methylcyclohept-3-ene-1,1-dicarboxylate. Colorless oil. 1H NMR (400 MHz, CDCl3): δ = 5.57 
(t, J = 6.2 Hz, 1H), 4.16 (q, J = 7.1 Hz, 4H), 2.64 (s, 2H), 2.19-2.16 (m, 2H), 2.07-2.03 
(m, 2H), 1.75 (s, 3H), 1.65-1.59 (m, 2H), 1.23 ppm (t, J = 7.1 Hz, 6H); 13C NMR (100 
MHz, CDCl3): δ = 172.0, 135.2, 127.7, 61.2, 55.8, 37.6, 36.9, 28.0, 26.7, 22.9, 14.2 
ppm; IR (film, cm-1): 3463, 2970, 2862, 1729, 1446, 1366, 1310, 1217, 1090, 1056, 
1030; MS (EI) m/z (%): 254 [M+] (15), 208 (20), 180 (22), 173 (100), 163 (14), 152 
(7), 135 (15), 127 (28), 107 (33), 91 (9), 79 (11); HRMS (ESI): m/z: calcd for C14H22O4 + Na: 277.1416; 
found: 277.1410. The analytical and spectroscopic data are in accordance with those reported in the 
literature.2 
(3R,4R)-3-Azido-4-benzyloxy-2,3,4,7-tetrahydroazepin-1-carbonic acid tert-butylester. A solution of 
complex 2 (8 mg, 9 μmol, 5 mol%) and anhydrous ZnCl2 (1.2 mg, 9 μmol) in CH2Cl2 (18 
mL) was stirred in a sealed flask for 30 min at 100°C. After this activation phase, 
(2R,3R)-allyl-(2-azido-3-benzyloxy-pent-4-enyl)-carbaminic acid tert-butylester (66 mg, 
0.177 mmol) was introduced and the solution stirred at reflux temperature under Ar 
for 30 min. All volatile materials were evaporated and the residue purified by flash 
chromatography (hexanes/EtOAc, 20:1) to give the title compound as a colorless oil (56 mg, 92%). 1H 
NMR (300 MHz, CD2Cl2): δ = 7.40-7.29 (m, 5H), 5.76 (br s, 2H), 4.67 (d, J = 11.5 Hz, 1H), 4.55 (d, J = 
11.5 Hz, 1H), 4.27-3.97 (m, 2H), 3.85-3.54 (m, 4H), 1.45 ppm (s, 9H); 13C NMR (75 MHz, CD2Cl2): δ = 
155.1, 138.3, 131.1, 129.8, 128.7, 128.3, 128.1, 80.5, 79.1, 72.3, 64.0, 48.8, 47.5, 28.4;  20D  = –26.3 
(2.7, CH2Cl2); IR (neat, cm
-1): 3065, 3031, 2976, 2927, 2857, 2108, 1699, 1657, 1496, 1456, 1393, 
1366, 1248, 1168, 1135, 1095, 737, 698; MS (EI) m/z : 344 ([M+], < 1), 260 (1), 225 (2), 186 (1), 180 
(3), 169 (14), 160 (6), 125 (11), 91 (100), 57 (57); HRMS (ESI): m/z: calcd for C18H24N4O3+H: 345.1927; 
found: 345.1921; elemental analysis calcd for C18H24N4O3 (344.41): C 62.77, H 7.02, N 16.27; found: C 
62.72, H 6.94, N 16.19. The analytical and spectroscopic data are in accordance with those reported 
in the literature.3 
                                                          
3
 A. Fürstner, O. R. Thiel, J. Org. Chem. 2000, 65, 1738-1742. 
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2,2-Dimethyl-6-phenyl-1-oxa-2-silacyclohex-3-ene. Obtained by Kugelrohr distillation (bp = 93-95°C, 
0.4 Torr)  as a colorless oil. 1H NMR (400 MHz, CDCl3): δ = 7.43 (dd, J = 8.8, 1.6 Hz, 2H), 
7.37 (td, J = 8.8, 1.6 Hz, 2H), 7.27 (tt, J = 8.8, 1.6 Hz, 1H), 6.86 (ddd, J = 14.0, 6.0, 2.4 Hz, 
1H), 5.89 (ddd, J = 14.0, 2.8, 0.8 Hz, 1H), 5.02 (dd, J = 10.0, 3.6 Hz, 1H), 2.47-2.33 (m, 
2H), 0.28 (s, 3H), 0.27 ppm (s, 3H); 13C NMR (100 MHz, CDCl3): δ = 147.2, 144.6, 128.5, 
127.6, 127.3, 125.7, 73.5, 39.1, 0.0, –0.4 ppm; IR (film, cm-1): 2958, 2855, 1587, 1249, 
1062, 955, 833, 785, 695; MS (EI) m/z (%): 204 [M+] (43), 189 (5), 130 (100), 111 (5), 98 (40), 83 (25), 
75 (6), 61 (5); HRMS (ESI): m/z: calcd for C12H16OSi : 204.0970; found: 204.0970. The analytical and 
spectroscopic data are in accordance with those reported in the literature.4 
2-Benzylbenzofuran. Colorless oil. 1H NMR (400 MHz, CDCl3): δ = 7.43-7.41 (m, 1H), 7.37-7.35 (m, 
1H), 7.30-7.24 (m, 4H), 7.23-7.10 (m, 3H), 6.32 (s, 1H), 4.06 ppm (s, 2H);13C 
NMR (100 MHz, CDCl3): δ = 157.9, 155.1, 137.4, 129.1, 128.8, 126.9, 123.6, 
122.7, 120.5, 111.1, 103.5, 35.1 ppm; IR (film, cm-1): 3029, 2906, 1738, 1585, 
1495, 1453, 1251, 1163, 952, 791, 739, 701; MS (EI) m/z (%): 208 [M+] (100), 
189 (4), 178 (14), 165 (3), 152 (3), 131 (32), 115 (3), 104 (4), 89 (7), 77 (5), 51 (3); HRMS (ESI): m/z: 
calcd for C15H12O: 208.0888; found: 208.0888. The analytical and spectroscopic data are in 
accordance with those reported in the literature.5 
Kinetic Resolution using [Mo(CHCMe2Ph)(NAr)((R)-(+)-tBu2Me4(biphen))(bipy)] Activated by ZnCl2. 
A solution containing complex 7 (12 mg, 13 μmol, 5 mol%) and anhydrous ZnCl2 (1.8 mg, 13 μmol) in 
toluene (1 mL) was stirred at 65°C for 1 h. After this activation phase, the mixture was allowed to 
reach ambient temperature before a solution of (6E)-6-methyl-5-tert-butyldimethylsiloxy-1,6-
octadiene (55 mg, 216 μmol) in toluene (1.2 mL) was introduced. The flask was sealed and stirring 
continued for 60 min before the reaction was stopped by the addition of MeOH (1 mL). All volatile 
materials were evaporated and the ring-closed product and unreacted starting material were 
separated by flash chromatography (hexanes). 
 (6E)-6-Methyl-5-tert-butyldimethylsiloxy-1,6-octadiene. Colorless oil (18 mg, 27%), ee = 99% 
(determined by GC using a chiral stationary phase: Ivadex-1/PS086 (dimethyl-pentyl-ß-
cyclodextrine, 25 m)); 1H NMR (400 MHz, CDCl3): δ = 5.87-5.77 (m, 1H), 5.38-5.32 (m, 
1H), 5.02-4.91 (m, 2H), 3.95 (t, J = 7.1 Hz, 1H), 2.10-1.91 (m, 2H), 1.66-1.44 (m, 8H), 0.87 
(s, 9H), 0.02 (s, 3H), –0.03 (s, 3H); 13C NMR (100 MHz, CDCl3): δ = 139.1, 138.4, 119.8, 
114.3, 78.2, 35.7, 30.3, 26.0, 18.4, 13.1, 10.9, –4.5, –4.8; IR (film, cm-1): 2929, 2858, 
1738, 1641, 1472, 1361, 1252, 1217, 1071, 909, 833, 772, 665; MS (EI) m/z (%): 254 [M+] (1); 239 (2), 
197 (64), 155 (8), 141 (3), 127 (4), 75 (100), 67 (3), 59 (4), 41 (7); HRMS (ESI): m/z: calcd for C15H30OSi 
+ H: 255.2144; found: 255.2144. 
2-Methyl-1-tert-butyldimethylsiloxy-2-cyclopentene. Colorless oil (18 mg, 33%), ee = 70% 
(determined by GC using a chiral stationary phase: BGB-176/SE-52 (2,3-dimethyl-6-tert-
butyldimethylsilyl-ß-cyclodextrine, 30 m)); 1H NMR (400 MHz, CDCl3): δ = 5.47-5.45 (m, 
1H), 4.66-4.63 (m, 1H), 2.40-2.32 (m, 1H), 2.28-2.20 (m, 1H), 2.18-2.10 (m, 1H), 1.71 (s, 
3H), 1.70-1.63 (m, 1H), 0.92 (s, 9H), 0.10 (s, 3H), 0.09 (s, 3H); 13C NMR (100 MHz, 
                                                          
4
 S. E. Denmark, S.-M. Yang, Org. Lett. 2001, 3, 1749–1752. 
5
 O. Fujimura, G. C. Fu, R. H. Grubbs J. Org. Chem. 1994, 59, 4029-4031. 
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CDCl3): δ = 142.2, 126.9, 80.3, 34.5, 29.8, 26.1, 14.0, –4.3, –4.6; IR (film, cm
-1): 2930, 2856, 1462, 
1354, 1249, 1080, 992, 884, 833, 772, 669; MS (EI) m/z (%): 212 [M+] (9), 197 (2), 137 (3), 155 (32), 75 
(100), 59 (3); HRMS (ESI): m/z: calcd for C12H24OSi: 212.1596; found: 212.1596. 
Desymmetrization. A solution of complex 7 (7 mg, 7 μmol, 5 mol%) and anhydrous ZnCl2 (1.0 mg, 
7 μmol) in toluene (0.5 mL) was stirred at 80°C for 30 min. After this activation phase, 
the mixture was allowed to reach ambient temperature before a solution of 3-allyl-
(2,4-dimethyl-1,4-pentadienyl) ether (22 mg, 145 μmol) in toluene (1.0 mL) was 
introduced. Stirring was continued for 6 h before the solvent was evaporated and the 
residue purified by flash chromatography (pentanes/ether, 9:1) to afford pure 2-iso-propenyl-3-
methyl-2,5-dihydrofuran (15 mg, 85%, 90% ee) as a colorless liquid. 1H NMR (400 MHz, CD2Cl2): δ = 
5.61 (sept, J = 1.8 Hz,  1H), 4.96-4.93 (m, 2H), 4.89 (quint, J = 1.6 Hz,  1H), 4.67-4.64 (m, 2H), 1.62-1.60 
(m, 6H); 13C NMR (100 MHz, CD2Cl2): δ = 145.8, 137.4, 122.0, 113.4, 93.3, 76.0, 15.9, 12.2; IR (neat, 
cm-1): 2849, 1604, 1495, 1450, 1184, 1067, 953, 904, 829, 731, 710, 695, 678; MS (EI) m/z (%): 124 
[M+] (11), 109 (100), 95 (20), 83 (88), 69 (37), 55 (51), 41 (39), 27 (24); HRMS (ESI): m/z: calcd for 
C8H12O: 124.0888; found: 124.0888. 
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